261 related articles for article (PubMed ID: 20018850)
21. Effects of AGXT2 variants on blood pressure and blood sugar among 750 older Japanese subjects recruited by the complete enumeration survey method.
Yoshino Y; Kumon H; Mori T; Yoshida T; Tachibana A; Shimizu H; Iga JI; Ueno SI
BMC Genomics; 2021 Apr; 22(1):287. PubMed ID: 33879046
[TBL] [Abstract][Full Text] [Related]
22. Genome-wide association study of L-arginine and dimethylarginines reveals novel metabolic pathway for symmetric dimethylarginine.
Lüneburg N; Lieb W; Zeller T; Chen MH; Maas R; Carter AM; Xanthakis V; Glazer NL; Schwedhelm E; Seshadri S; Ikram MA; Longstreth WT; Fornage M; König IR; Loley C; Ojeda FM; Schillert A; Wang TJ; Sticht H; Kittel A; König J; Benjamin EJ; Sullivan LM; Bernges I; Anderssohn M; Ziegler A; Gieger C; Illig T; Meisinger C; Wichmann HE; Wild PS; Schunkert H; Psaty BM; Wiggins KL; Heckbert SR; Smith N; Lackner K; Lunetta KL; Blankenberg S; Erdmann J; Munzel T; Grant PJ; Vasan RS; Böger RH
Circ Cardiovasc Genet; 2014 Dec; 7(6):864-72. PubMed ID: 25245031
[TBL] [Abstract][Full Text] [Related]
23. Age-related changes in ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion.
Trocha M; Merwid-Ląd A; Chlebda-Sieragowska E; Szuba A; Pieśniewska M; Fereniec-Gołębiewska L; Kwiatkowska J; Szeląg A; Sozański T
Exp Gerontol; 2014 Feb; 50():45-51. PubMed ID: 24269305
[TBL] [Abstract][Full Text] [Related]
24. Reduced Renal Methylarginine Metabolism Protects against Progressive Kidney Damage.
Tomlinson JA; Caplin B; Boruc O; Bruce-Cobbold C; Cutillas P; Dormann D; Faull P; Grossman RC; Khadayate S; Mas VR; Nitsch DD; Wang Z; Norman JT; Wilcox CS; Wheeler DC; Leiper J
J Am Soc Nephrol; 2015 Dec; 26(12):3045-59. PubMed ID: 25855779
[TBL] [Abstract][Full Text] [Related]
25. Metabolism of methylarginines by human vasculature; implications for the regulation of nitric oxide synthesis.
MacAllister RJ; Fickling SA; Whitley GS; Vallance P
Br J Pharmacol; 1994 May; 112(1):43-8. PubMed ID: 7518309
[TBL] [Abstract][Full Text] [Related]
26. Association of the AGXT2 V140I polymorphism with risk for coronary heart disease in a Chinese population.
Zhou JP; Bai YP; Hu XL; Kuang DB; Shi RZ; Xiong Y; Zhang W; Xia J; Chen BL; Yang TL; Chen XP
J Atheroscler Thromb; 2014; 21(10):1022-30. PubMed ID: 24834905
[TBL] [Abstract][Full Text] [Related]
27. The prominent role of the liver in the elimination of asymmetric dimethylarginine (ADMA) and the consequences of impaired hepatic function.
Richir MC; Bouwman RH; Teerlink T; Siroen MP; de Vries TP; van Leeuwen PA
JPEN J Parenter Enteral Nutr; 2008; 32(6):613-21. PubMed ID: 18974239
[TBL] [Abstract][Full Text] [Related]
28. Coordinated regulation of dimethylarginine dimethylaminohydrolase-1 and cationic amino acid transporter-1 by farnesoid X receptor in mouse liver and kidney and its implication in the control of blood levels of asymmetric dimethylarginine.
Li J; Wilson A; Gao X; Kuruba R; Liu Y; Poloyac S; Pitt B; Xie W; Li S
J Pharmacol Exp Ther; 2009 Oct; 331(1):234-43. PubMed ID: 19605523
[TBL] [Abstract][Full Text] [Related]
29. The impact of asymmetric dimethylarginine (ADAMA), the endogenous nitric oxide (NO) synthase inhibitor, to the pathogenesis of gastric mucosal damage.
Szlachcic A; Krzysiek-Maczka G; Pajdo R; Targosz A; Magierowski M; Jasnos K; Drozdowicz D; Kwiecien S; Brzozowski T
Curr Pharm Des; 2013; 19(1):90-7. PubMed ID: 22950506
[TBL] [Abstract][Full Text] [Related]
30. Nitric oxide synthase inhibitors and cerebral vasospasm.
Jung CS
Acta Neurochir Suppl; 2011; 110(Pt 1):87-91. PubMed ID: 21116921
[TBL] [Abstract][Full Text] [Related]
31. The therapeutic potential of targeting endogenous inhibitors of nitric oxide synthesis.
Leiper J; Nandi M
Nat Rev Drug Discov; 2011 Apr; 10(4):277-91. PubMed ID: 21455237
[TBL] [Abstract][Full Text] [Related]
32. Estradiol counteracts oxidized LDL-induced asymmetric dimethylarginine production by cultured human endothelial cells.
Monsalve E; Oviedo PJ; García-Pérez MA; Tarín JJ; Cano A; Hermenegildo C
Cardiovasc Res; 2007 Jan; 73(1):66-72. PubMed ID: 17097077
[TBL] [Abstract][Full Text] [Related]
33. Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems.
Palm F; Onozato ML; Luo Z; Wilcox CS
Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3227-45. PubMed ID: 17933965
[TBL] [Abstract][Full Text] [Related]
34. Asymmetric Dimethylarginine Limits the Efficacy of Simvastatin Activating Endothelial Nitric Oxide Synthase.
Hsu CP; Zhao JF; Lin SJ; Shyue SK; Guo BC; Lu TM; Lee TS
J Am Heart Assoc; 2016 Apr; 5(4):e003327. PubMed ID: 27091343
[TBL] [Abstract][Full Text] [Related]
35. Enhancing kidney DDAH-1 expression by adenovirus delivery reduces ADMA and ameliorates diabetic nephropathy.
Wetzel MD; Gao T; Stanley K; Cooper TK; Morris SM; Awad AS
Am J Physiol Renal Physiol; 2020 Feb; 318(2):F509-F517. PubMed ID: 31904280
[TBL] [Abstract][Full Text] [Related]
36. Asymmetric dimethylarginine as a mediator of vascular dysfunction in cirrhosis.
Lluch P; Segarra G; Medina P
World J Gastroenterol; 2015 Aug; 21(32):9466-75. PubMed ID: 26327755
[TBL] [Abstract][Full Text] [Related]
37. [Asymmetric dimethylarginine: metabolism, arginine paradox, pathophysiology].
Gilinskiĭ MA
Usp Fiziol Nauk; 2007; 38(3):21-39. PubMed ID: 17977229
[TBL] [Abstract][Full Text] [Related]
38. Arginine, arginine analogs and nitric oxide production in chronic kidney disease.
Baylis C
Nat Clin Pract Nephrol; 2006 Apr; 2(4):209-20. PubMed ID: 16932427
[TBL] [Abstract][Full Text] [Related]
39. An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes.
Böger RH; Bode-Böger SM; Tsao PS; Lin PS; Chan JR; Cooke JP
J Am Coll Cardiol; 2000 Dec; 36(7):2287-95. PubMed ID: 11127475
[TBL] [Abstract][Full Text] [Related]
40. Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase.
Achan V; Broadhead M; Malaki M; Whitley G; Leiper J; MacAllister R; Vallance P
Arterioscler Thromb Vasc Biol; 2003 Aug; 23(8):1455-9. PubMed ID: 12805079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
